Recruiting studies: Alzheimer Disease 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Phase 1 · 13 location(s) · Alnylam Pharmaceuticals · NCT07214727 A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Phase 2 · 72 location(s) · Eli Lilly and Company · NCT07589595 Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
NA · 1 location(s) · Vincent Tay Khwee Soon · NCT06965062 Physical Activity and Community EmPOWERment Project
NA · 2 location(s) · University of North Carolina, Chapel Hill · NCT06740162 Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03878121 PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Phase 1 · 1 location(s) · National Institute of Mental Health (NIMH) · NCT04396873 Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · 12 location(s) · Alphyn Biologics · NCT06855745 Lecanemab for Early Onset Familial Alzheimer's Disease
Phase N/A · 15 location(s) · RenJi Hospital · NCT06883019 Innate Immunity Stimulation Via TLR9 in Early AD
Phase 1 · 1 location(s) · NYU Langone Health · NCT05606341 A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participant
Phase 1 · 1 location(s) · Amyloid Solution Inc · NCT06786676 Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
Phase 2 · 1 location(s) · Bernard (Barry) Baumel · NCT06781333 NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106 A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Phase 1 · 2 location(s) · University College, London · NCT06372821 Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's
Phase 2 · 1 location(s) · Bernard (Barry) Baumel · NCT07512362 [18F]ACI-19626 PET in TDP-43 Proteinopathies
EARLY_Phase 1 · 1 location(s) · AC Immune SA · NCT06891716 Dominantly Inherited Alzheimer Network (DIAN)
Phase N/A · 26 location(s) · Washington University School of Medicine · NCT00869817 Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheime
Phase 1 · 1 location(s) · Regeneration Biomedical, Inc. · NCT05667649 Clinical Trial on Agitation in Alzheimer's Dementia
Phase 2 · 31 location(s) · IGC Pharma, LLC · NCT05543681 A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · 1 location(s) · Luye Pharma Group Ltd. · NCT07230652 A Study of LY3439539 in Participants With Alzheimer's Disease
Phase 1 · 9 location(s) · Eli Lilly and Company · NCT07598370 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · 116 location(s) · Bristol-Myers Squibb · NCT06976216 Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
Phase 1/Phase 2 · 3 location(s) · Arrowhead Pharmaceuticals · NCT07221344 BnH-015B Clinical Trial in Moderate Alzheimer's Disease
Phase 1 · 1 location(s) · BnH Research · NCT06535308 Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/Phase 2 · 3 location(s) · Ashvattha Therapeutics, Inc. · NCT05395624

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →